Close

China Shenghuo Q2 sales climb 58%

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Transforming Pharma Cold Chain Using IoT Real-Time Tracking

Transforming Pharmaceutical Cold Chain Through Connected Intelligence The pharmaceutical industry...

Pharma Cold Chain Workforce Competency Frameworks

Building Excellence Through Structured Competency Development The pharmaceutical cold chain...

China Shenghuo, engaged in the research, development, manufacture and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products, has reported sales of $10.9m for the second quarter ended 30 June 2011, an increase of 58% compared to $6.88m for the same period in 2010. The increase in sales was primarily due to the increase in company’s main product Xuesaitong in Tianjin City and Yunnan Province and enhanced sales promotion in Yunnan Province.China Shenghuo’s net income was $105,390, compared to net loss of $37,910 for the same period in the prior year.

The company’s income from operations was $556,930 for the second quarter ended 30 June 2011, compared to $334, 554 for the same period in 2010.For the six months ended 30 June 2011 sales were $20.34m, compared to $14.79m for the same period in 2010.Net loss was $191,091 for the six months ended 30 June 2011, as compared to $348,379 for the same period prior year.For the six months ended 30 June 2011, the company’s income from operations were $ 964,494 as compared to operating income of $ 348,379 for the same period in 2010.

Latest stories

Related stories

Cryogenic Identification Solutions for Pharma Supply Chains

Maintaining Track-and-Trace Integrity in Extreme Temperature Environments The pharmaceutical industry's...

Predictive AI in Pharma Cold Chain Risk Management

Revolutionizing Cold Chain Management Through Artificial Intelligence The pharmaceutical industry...

Transforming Pharma Cold Chain Using IoT Real-Time Tracking

Transforming Pharmaceutical Cold Chain Through Connected Intelligence The pharmaceutical industry...

Pharma Cold Chain Workforce Competency Frameworks

Building Excellence Through Structured Competency Development The pharmaceutical cold chain...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back